key: cord-0752415-kgaxy70z authors: Bhargava, Ashish; Riederer, Kathleen; Sharma, Mamta; Fukushima, Elisa Akagi; Johnson, Leonard; Saravolatz, Louis title: High Rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 Patients Presenting with Bacteremia upon Hospital Admission date: 2021-08-18 journal: Am J Infect Control DOI: 10.1016/j.ajic.2021.08.010 sha: 5ea80ae5b824354d16405da49995d11dc41dc609 doc_id: 752415 cord_uid: kgaxy70z We investigated the clinical implications of bacteremia among hospitalized COVID-19 patients. Higher rates (52.1%) of multidrug resistant organisms (MDRO) were noted on hospital admission compared to nosocomial acquisition (25.0%). Methicillin resistant Staphylococcus aureus was the predominant pathogen. Bacteremia with MDRO should be considered in the differential diagnosis among at risk populations especially those admitted from nursing facilities. Since its first detection in 2019, the novel pathogen, severe acute respiratory syndrome coronavirus (SARS-CoV-2) has since spread to a pandemic level causing COVID-19. Without a clear treatment strategy in the early months of the pandemic, antibiotics were often used for possible bacterial coinfections. [1] [2] Blood culture (BC) was also performed to assess the presence of bacteremia that could complicate the clinical course. 3 We investigated COVID-19 patients with bacteremia to ascertain the clinical implications for patients presenting with dual pathogens. We identified 290 hospitalized patients with BC during the study period after exclusion of relapse and BC contaminants. There were 23/266 (8.6%) patients with positive BC on admission, all drawn within 26 hours of admission, and the majority were drawn in the emergency unit (Table1). Nosocomial bacteremia was noted in 16 patients, 14 (87.5%) of them had BC done when they were in Intensive Care Units (ICU). Similar patient characteristics revealed that most were black (82.6% vs 75%) males (78.3% vs 62.5%) < age 70 years (60.9% vs 75%) and admitted from nursing facilities (60.9% vs 37.5%) for bloodstream infections on admission and nosocomial bacteremia cases, respectively ( Table 1 ). All 23 cases of BSI on admission were monomicrobial. Organisms identified were Staphylococcus aureus (8) In our study, the rate of positive BC on admission among the hospitalized COVID-19 patients was 8.6 % which is higher than 2.5-2.9% reported in early literature. 1 This is likely due to the higher number of patients (65%) with positive BC on admission from nursing facilities. We previously reported that admission from nursing facilities was an independent risk factor for bacteremia on admission. 5 Similar findings of higher community-onset bacterial infection were reported among the patients admitted from a skilled nursing facility. 1 In our study, in-hospital mortality among patients with dual infection was 64.1%, compared to 53.1% reported in a multicenter study. 6 In our cohort, gram positive MDRO BSIs were more common either on admission or nosocomially acquired. High rates of resistant BSIs on admission could be explained by those presenting from nursing facilities. A previous study on community onset BSI among non-COVID-19 patients reported that admission from a nursing facility was an independent risk factor for MDRO infections. 7 Indwelling devices, such as urinary catheters and feeding tubes, are frequently used in nursing facilities. Compared with residents from nursing facilities without indwelling devices, residents with indwelling devices have a higher prevalence of MDRO colonization. 8 Our study limitations are a single center study with a small sample size. Nevertheless, our study strength is inclusion of nursing home patients with severe COVID-19 that had BSIs on admission. Larger studies may further validate our findings. Higher rates of MDRO BSIs were noted among the hospitalized COVID-19 patients on hospital admission. Gram positive MDRO bloodstream infections were more common either on admission or nosocomially acquired with MRSA being the most common pathogen. Based on our findings in patients presenting from the nursing home with sepsis, MDRO BSI should be considered in the differential diagnosis and efforts should be made to avoid delaying the administration of appropriate antibiotic therapy. Empiric Antibacterial Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19: A Multi-Hospital Cohort Study Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship Bacteremia and Blood Culture Utilization during COVID-19 Surge in New York City Clinical Features and Risk Factors for Community Onset Bloodstream Infections among COVID-19 Patients Risk Factors and Outcomes of Hospitalized Patients with Severe COVID-19 and Secondary Bloodstream Infections: A Multicenter, Case-Control Study Community-onset bloodstream infection with multidrug-resistant organisms: a matched case-control study A targeted infection prevention intervention in nursing home residents with indwelling devices: a randomized clinical trial Acknowledgment: We thank Ms. Debra Cicchini for helping us to access the journal articles through the electronic library Funding: There was no funding involved in our study.All the authors have no association that might pose a conflict of interest.